Get started
Author

Maria G. Pilo

Observed names: G. Pilo, Maria, M G Pilo, M Pilo, Maria G Pilo, Maria Giulia Pilo, Maria Pilo
OpenAlex ID: A5024098690
Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans
2019 · Li Che, Wenna Chi, et al. · Gut · 203
PDF
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c‐Myc‐driven hepatocarcinogenesis
2017 · Pin Liu, Mengmeng Ge, et al. · Hepatology · 187
PDF
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice
2017 · Shanshan Zhang, Xinhua Song, et al. · Journal of Hepatology · 151
PDF
Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice
2016 · Junjie Hu, Li Che, et al. · Scientific Reports · 123
PDF
Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans
2016 · Lei Li, Li Che, et al. · Hepatology · 105
Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic Cholangiocarcinoma
2018 · Xinhua Song, Xianqiong Liu, et al. · Clinical Cancer Research · 84
PDF
4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N‐Ras proto‐oncogenes in mice
2014 · Chunmei Wang, Antonio Cigliano, et al. · Hepatology · 83
Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma
2019 · Li Che, Panagiotis Paliogiannis, et al. · Frontiers in Oncology · 74
PDF
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells
2016 · Dan Cao, Xinhua Song, et al. · Liver International · 70
PDF
Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma
2017 · Li Che, Maria G. Pilo, et al. · Cell Cycle · 62
PDF
Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans
2016 · L Che, B Fan, et al. · Oncogenesis · 55
PDF
PI3K/AKT/mTOR pathway plays a major pathogenetic role in glycogen accumulation and tumor development in renal distal tubules of rats and men
2015 · Silvia Ribback, Antonio Cigliano, et al. · Oncotarget · 51
PDF
Loss of Pten synergizes with c-Met to promote hepatocellular carcinoma development via mTORC2 pathway
2018 · Zhong Xu, Junjie Hu, et al. · Experimental & Molecular Medicine · 49
PDF
Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade
2017 · Jiaoyuan Jia, Yu Qiao, et al. · PLoS ONE · 39
PDF
The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
2022 · Antonio Cigliano, Shanshan Zhang, et al. · Journal of Experimental & Clinical Cancer Research · 35
PDF
Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice
2017 · Antonio Cigliano, Chunmei Wang, et al. · Oncotarget · 34
PDF
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis
2017 · Antonio Cigliano, Maria G. Pilo, et al. · Oncotarget · 33
PDF
Activated mutant forms of PIK 3 CA cooperate with RasV12 or c‐Met to induce liver tumour formation in mice via AKT 2/ mTORC 1 cascade
2015 · Chunmei Wang, Li Che, et al. · Liver International · 31
Functional role of SGK3 in PI3K/Pten driven liver tumor development
2019 · Hui Cao, Zhong Xu, et al. · BMC Cancer · 23
PDF
SCD1 Expression Is Dispensable for Hepatocarcinogenesis Induced by AKT and Ras Oncogenes in Mice
2013 · Lei Li, Chunmei Wang, et al. · PLoS ONE · 23
PDF
Oncogene-dependent addiction to carbohydrate-responsive element binding protein in hepatocellular carcinoma
2018 · Silvia Ribback, Li Che, et al. · Cell Cycle · 22
PDF
Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma
2019 · Antonio Cigliano, Maria Giulia Pilo, et al. · Medicina · 13
PDF
The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models
2016 · Silvia Ribback, Verena Sailer, et al. · International Journal of Molecular Sciences · 7
PDF
The pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice
2018 · K Evert, S Zhang, et al. · Zeitschrift für Gastroenterologie · 3
Corrigendum: Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma
2022 · Li Che, Panagiotis Paliogiannis, et al. · Frontiers in Oncology · 2
PDF
Works count: 32
Citation count: 1,563
H-index: 21
I10-index: 22
Year
Topic
Type